BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Diagnosis
164 results:

  • 1. Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience.
    Moretto R; Germani MM; Borelli B; Conca V; Rossini D; Boraschi P; Donati F; Urbani L; Lonardi S; Bergamo F; Cerma K; Ramondo G; D'Amico FE; Salvatore L; Valente G; Barbaro B; Giuliante F; Di Maio M; Masi G; Cremolini C
    ESMO Open; 2024 Apr; 9(4):102991. PubMed ID: 38631269
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Extracellular Vesicles Contribute to Viral-Induced Hepatocellular Carcinoma: Understanding Their Involvement in Viral Hepatitis and Their Potential as Biomarkers for Early Hepatocellular Carcinoma Detection.
    Tahir F; Farooq M; Malik MA; Manzoor S
    Viral Immunol; 2024 Apr; 37(3):159-166. PubMed ID: 38588555
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. SUMOylation of annexin A6 retards cell migration and tumor growth by suppressing RHOU/akt1-involved EMT in hepatocellular carcinoma.
    Yang Y; Huang L; Zhang N; Deng YN; Cao X; Liang Y; Hou H; Luo Y; Yang Y; Li Q; Liang S
    Cell Commun Signal; 2024 Apr; 22(1):206. PubMed ID: 38566133
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
    Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
    J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Noncoding RNAs and programmed cell death in hepatocellular carcinoma: Significant role of epigenetic modifications in prognosis, chemoresistance, and tumor recurrence rate.
    Arefnezhad R; Ashna S; Rezaei-Tazangi F; Arfazadeh SM; Seyedsalehie SS; Yeganeafrouz S; Aghaei M; Sanandaji M; Davoodi R; Abadi SRK; Vosough M
    Cell Biol Int; 2024 May; 48(5):556-576. PubMed ID: 38411312
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial.
    Noor NM; Lee JC; Bond S; Dowling F; Brezina B; Patel KV; Ahmad T; Banim PJ; Berrill JW; Cooney R; De La Revilla Negro J; de Silva S; Din S; Durai D; Gordon JN; Irving PM; Johnson M; Kent AJ; Kok KB; Moran GW; Mowat C; Patel P; Probert CS; Raine T; Saich R; Seward A; Sharpstone D; Smith MA; Subramanian S; Upponi SS; Wiles A; Williams HRT; van den Brink GR; Vermeire S; Jairath V; D'Haens GR; McKinney EF; Lyons PA; Lindsay JO; Kennedy NA; Smith KGC; Parkes M;
    Lancet Gastroenterol Hepatol; 2024 May; 9(5):415-427. PubMed ID: 38402895
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. USP14 exhibits high expression levels in hepatocellular carcinoma and plays a crucial role in promoting the growth of liver cancer cells through the HK2/akt/P62 axis.
    Zhang N; Zhang H; Yang X; Xue Q; Wang Q; Chang R; Zhu L; Chen Z; Liu X
    BMC Cancer; 2024 Feb; 24(1):237. PubMed ID: 38383348
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Dynamic regulation of EXO1 promotes the progression from liver fibrosis to HCC through TGF-β1/Smad signaling feedback loop.
    Li M; Huang F; Zhu W; Peng Y; Xu F; Li W; Zhao Q; Liu L
    Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38126949
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. NIR-II fluorescence-guided liver cancer surgery by a small molecular HDAC6 targeting probe.
    Wang B; Tang C; Lin E; Jia X; Xie G; Li P; Li D; Yang Q; Guo X; Cao C; Shi X; Zou B; Cai C; Tian J; Hu Z; Li J
    EBioMedicine; 2023 Dec; 98():104880. PubMed ID: 38035463
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Untargeted metabolomic profiles reveal widespread metabolic perturbations and identify candidate biomarkers in aminoaciduric canine hypoaminoacidemic hepatopathy syndrome.
    Loftus JP; Rubio MED; Yant J; Bichoupan A; Zhang S; Miller AJ; Center SA; Ruiz MDR; Macho LP
    Am J Vet Res; 2023 Dec; 84(12):. PubMed ID: 37871610
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Case Report: Complete pathological remission of human chorionic gonadotrophin-producing gallbladder carcinoma with multiple liver metastases after treatment with chemotherapy plus an immune checkpoint inhibitor.
    Wang Q; Mu Y; Ji S; Liu Y; Lou Y; Wei S; Dong X; Zhang B
    Front Immunol; 2023; 14():1173520. PubMed ID: 37841278
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Deep learning imaging reconstruction of reduced-dose 40 keV virtual monoenergetic imaging for early detection of colorectal cancer liver metastases.
    Li S; Yuan L; Lu T; Yang X; Ren W; Wang L; Zhao J; Deng J; Liu X; Xue C; Sun Q; Zhang W; Zhou J
    Eur J Radiol; 2023 Nov; 168():111128. PubMed ID: 37816301
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Early death after a diagnosis of metastatic solid cancer-raising awareness and identifying risk factors from the SEER database.
    Globus O; Sagie S; Lavine N; Barchana DI; Urban D
    PLoS One; 2023; 18(9):e0281561. PubMed ID: 37751439
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. CHSY1 promotes CD8
    Sun G; Zhao S; Fan Z; Wang Y; Liu H; Cao H; Sun G; Huang T; Cai H; Pan H; Rong D; Gao Y; Tang W
    J Exp Clin Cancer Res; 2023 Sep; 42(1):248. PubMed ID: 37749638
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Combining brushing cytology with simultaneous vacuum aspiration in suspicious biliopancreatic malignancies: A multicenter propensity score-matched study (with video).
    Yu Y; Xia M; Fu S; Ni J; Peng K; Mao Y; Xie N; Luo S; Lu L; Luo H; Wan X; Hu B; Li B
    Dig Liver Dis; 2024 Apr; 56(4):641-647. PubMed ID: 37748937
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinical manifestation, staging and prognosis of hepatocellular carcinoma in Gambian patients.
    Bittaye SO; Kambi A; Tekanyi MAI; Tamba S; Sanneh L; Sisawo MM; Jatta A; Fatty G; Jeng A; Jallow MS; Leigh O; Njie R
    BMC Gastroenterol; 2023 Sep; 23(1):321. PubMed ID: 37730538
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Effects of LAIR-1 on hepatocellular carcinoma cell proliferation and invasion via PI3K-akt-mTOR pathway regulation.
    Zhou T; Liu L; Lan H; Fang D
    Immun Inflamm Dis; 2023 Aug; 11(8):e982. PubMed ID: 37647449
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant CTNNB1 mutations.
    Xu Y; Zhang X; Zhang R; Sun Y; Liu J; Luo C; Yang J; Fang W; Guo Q; Wei L
    Cancer Lett; 2023 Jul; 566():216240. PubMed ID: 37217071
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Novel roles of karyopherin subunit alpha 2 in hepatocellular carcinoma.
    Yang X; Wang H; Zhang L; Yao S; Dai J; Wen G; An J; Jin H; Du Q; Hu Y; Zheng L; Chen X; Yi Z; Tuo B
    Biomed Pharmacother; 2023 Jul; 163():114792. PubMed ID: 37121148
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The Diagnostic and Therapeutic Value of NCAPG as a Proposed Biomarker Candidate in Acute liver Failure.
    Zhang L; Ma T; Yan Y; Chen YY; Zhu XH; Ren HZ
    Comb Chem High Throughput Screen; 2023; 26(15):2738-2748. PubMed ID: 37066775
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.